Condition: Colorectal Neoplasms · Sponsor: Surgimab
The performance of SGM-101, an intraoperative imaging agent, will be compared to that of standard "white light" visualization during surgical resections of colorectal cancer.
This description comes directly from the study's public registry record.
John Warner, JD, MPA · 8123257657 · johna.warner@outlook.com
Françoise Cailler, PhD · +33 467 798 381 · fcailler@surgimab.com
Always discuss trial participation with your own doctor first.
| City of Hope National Medical Center | Duarte, California, United States | Recruiting |
| Moores Cancer Center - UCSD Health | La Jolla, California, United States | Recruiting |
| Cleveland Clinic Florida | Weston, Florida, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Not Yet Recruiting |
| University of Massachusetts | Worcester, Massachusetts, United States | Recruiting |
| Perelman Center for Advanced Medicine | Philadelphia, Pennsylvania, United States | Recruiting |
| Universitätsmedizin Göttingen, Klinik für Allgemein- Viszeral- und Kinderchirurgie | Göttingen, Germany | Recruiting |
| Fondazione IRCCS Policlinico San Matteo | Pavia, Lombardy, Italy | Recruiting |
| Catharina Ziekenhuis Eindhoven | Eindhoven, Netherlands | Recruiting |
| Leiden University Medical Center | Leiden, Netherlands | Recruiting |
| Erasmus MC | Rotterdam, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03659448